colorectal cancer
Conditions
Interventions
To administrate the ethical liquid enteral nutrition formula (Racol NF) 400kcal per day from the day start chemotherapy to the day complete of the study.
Sponsors
Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who will receive chemotherapy to the colorectal area 2. Patients who have histologically diagnosed colorectal carcinoma. 3. Patients aged 20 years and older at the time of informed consent. 4. Patients with ECOG performance status of 0 to 2. 5. Patients who not have severe disorder to heart, lung, bone marrow, liver and kidney. 6. Patients without severe complications. 7. Patients and legal representative have given voluntary written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe narrowing of colon lumen 2. Patients with short-bowel syndrome 3. Patients with severe liver/renal disorder 4. Patients with severe diabetes mellitus (HbA1c >7.0%) 5. Patients with inborn error of amino acid metabolism 6. Patients with allergy to any ingredient of milk. 7. Patients with abnormal electrolyte metabolism 8. Patient s with hemophilia 9. Patients who have received blood transfusion within a month 10. Pregnant women or women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight reduction rate during the chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematology and blood chemistry, (Alb, Pre-Alb, total cholesterol, total lymphocyte count, total protein, CRP, Ghrelin) Occurrence of adverse event The ratio of the patients who completed the treatment course ADL (Activities of Daily Living) | — |
Countries
Japan
Contacts
Public ContactKiyotaka Kurachi
Hamamatsu University School of Medicine Department of Second Surgery
Outcome results
None listed